Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > Every week CXR debt seems to go up 1 Billion LOL
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by MrHuloton Apr 19, 2017 11:40am
340 Views
Post# 26137405

RE:RE:RE:RE:RE:RE:RE:Every week CXR debt seems to go up 1 Billion LOL

RE:RE:RE:RE:RE:RE:RE:Every week CXR debt seems to go up 1 Billion LOLYou Cockroaches follow “selective” accounting. The Cinven payout means there debt went down 120 million. Also, you are assuming they made no  money in Q1. We know they did because they are a cash-flow machine. But nice try.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities